1932

Abstract

Rare genetic variants have illuminated mechanisms of common diseases and have even led to novel treatment approaches. Some copy number variants (CNVs) have been associated with extraordinary risk for complex neuropsychiatric phenotypes and thus offer a valuable entry point for investigating the biological mechanisms and pathways underlying autism, intellectual disability, and schizophrenia, among other neuropsychiatric disorders. For example, cellular and animal models of multiple CNVs have identified mitochondrial dysregulation as a key pathway underlying these disorders. In the clinic, there is a growing potential for improving the quality of life of individuals affected by these rare variants. Early targeted intervention leveraging data from robust clinical studies will be critical for providing patients and their families with the best possible outcomes. In this review, we highlight the current challenges and opportunities in the field of neurodevelopmental CNV research in both the lab and the clinic.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-genom-121222-120601
2025-04-25
2025-05-14
Loading full text...

Full text loading...

/content/journals/10.1146/annurev-genom-121222-120601
Loading
  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error